Morgan Stanley’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.53M Buy
3,628,528
+3,060,916
+539% +$2.13M ﹤0.01% 4557
2025
Q1
$619K Sell
567,612
-537,144
-49% -$585K ﹤0.01% 5237
2024
Q4
$1.1M Buy
1,104,756
+714,046
+183% +$714K ﹤0.01% 5038
2024
Q3
$645K Buy
390,710
+365,306
+1,438% +$603K ﹤0.01% 5280
2024
Q2
$28.2K Sell
25,404
-4,905
-16% -$5.44K ﹤0.01% 6356
2024
Q1
$40K Sell
30,309
-2,461
-8% -$3.25K ﹤0.01% 6300
2023
Q4
$49.2K Buy
32,770
+676
+2% +$1.01K ﹤0.01% 6389
2023
Q3
$47.2K Sell
32,094
-25,011
-44% -$36.8K ﹤0.01% 6191
2023
Q2
$143K Sell
57,105
-467,370
-89% -$1.17M ﹤0.01% 5790
2023
Q1
$781K Buy
524,475
+50,098
+11% +$74.6K ﹤0.01% 5006
2022
Q4
$664K Buy
474,377
+456,492
+2,552% +$639K ﹤0.01% 5088
2022
Q3
$56K Sell
17,885
-21,352
-54% -$66.9K ﹤0.01% 6358
2022
Q2
$136K Buy
39,237
+15,427
+65% +$53.5K ﹤0.01% 6105
2022
Q1
$269K Sell
23,810
-35,408
-60% -$400K ﹤0.01% 5754
2021
Q4
$567K Buy
59,218
+48,433
+449% +$464K ﹤0.01% 5469
2021
Q3
$95K Buy
10,785
+2,023
+23% +$17.8K ﹤0.01% 6408
2021
Q2
$108K Buy
8,762
+8,700
+14,032% +$107K ﹤0.01% 6319
2021
Q1
$1K Sell
62
-4,117
-99% -$66.4K ﹤0.01% 7350
2020
Q4
$64K Buy
4,179
+3,487
+504% +$53.4K ﹤0.01% 6076
2020
Q3
$13K Sell
692
-476
-41% -$8.94K ﹤0.01% 6188
2020
Q2
$14K Buy
1,168
+1,021
+695% +$12.2K ﹤0.01% 6079
2020
Q1
$1K Hold
147
﹤0.01% 6463
2019
Q4
$1K Sell
147
-1
-0.7% -$7 ﹤0.01% 6567
2019
Q3
$1K Sell
148
-101
-41% -$682 ﹤0.01% 6548
2019
Q2
$3K Sell
249
-211
-46% -$2.54K ﹤0.01% 6404
2019
Q1
$4K Sell
460
-1,568
-77% -$13.6K ﹤0.01% 6357
2018
Q4
$15K Sell
2,028
-2,040
-50% -$15.1K ﹤0.01% 6077
2018
Q3
$45K Buy
4,068
+2,263
+125% +$25K ﹤0.01% 5903
2018
Q2
$495K Buy
1,805
+736
+69% +$202K ﹤0.01% 5108
2018
Q1
$291K Buy
1,069
+426
+66% +$116K ﹤0.01% 5300
2017
Q4
$153K Buy
643
+611
+1,909% +$145K ﹤0.01% 5503
2017
Q3
$6K Sell
32
-62
-66% -$11.6K ﹤0.01% 6257
2017
Q2
$11K Sell
94
-712
-88% -$83.3K ﹤0.01% 6216
2017
Q1
$129K Sell
806
-948
-54% -$152K ﹤0.01% 5505
2016
Q4
$305K Buy
1,754
+1,593
+989% +$277K ﹤0.01% 5178
2016
Q3
$39K Buy
161
+80
+99% +$19.4K ﹤0.01% 5686
2016
Q2
$20K Sell
81
-162
-67% -$40K ﹤0.01% 5851
2016
Q1
$88K Sell
243
-1,105
-82% -$400K ﹤0.01% 5373
2015
Q4
$621K Buy
1,348
+1,227
+1,014% +$565K ﹤0.01% 4381
2015
Q3
$19K Sell
121
-42
-26% -$6.6K ﹤0.01% 6063
2015
Q2
$138K Sell
163
-133
-45% -$113K ﹤0.01% 5429
2015
Q1
$295K Buy
296
+50
+20% +$49.8K ﹤0.01% 4989
2014
Q4
$245K Buy
246
+239
+3,414% +$238K ﹤0.01% 5121
2014
Q3
$6K Sell
7
-26
-79% -$22.3K ﹤0.01% 6297
2014
Q2
$36K Buy
+33
New +$36K ﹤0.01% 5869